| No. |
Name
Length
|
Chromosome No./Scaffold Id
Scaffold Length |
BLAST (vs nr) |
Gene ontology |
| 3061 |
O_ErmoMG14729_5prime_partial:A_ErmoMG_comp36876_c0_seq1
340bp |
|
|
| GO:0000002 |
P |
mitochondrial genome maintenance |
| GO:0004518 |
F |
nuclease activity |
| GO:0004527 |
F |
exonuclease activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006264 |
P |
mitochondrial DNA replication |
| GO:0006281 |
P |
DNA repair |
| GO:0006974 |
P |
cellular response to DNA damage stimulus |
| GO:0008297 |
F |
single-stranded DNA exodeoxyribonuclease activity |
| GO:0016787 |
F |
hydrolase activity |
| GO:0043504 |
P |
mitochondrial DNA repair |
| GO:0090305 |
P |
nucleic acid phosphodiester bond hydrolysis |
|
| 3062 |
O_ErmoMG1472_3prime_partial:A_ErmoMG_comp19775_c0_seq2
249bp |
|
PREDICTED:_conserved_oligomeric_Golgi_complex_subunit_2_[Amyelois_transitella] |
| GO:0000139 |
C |
Golgi membrane |
| GO:0005794 |
C |
Golgi apparatus |
| GO:0006810 |
P |
transport |
| GO:0006891 |
P |
intra-Golgi vesicle-mediated transport |
| GO:0007030 |
P |
Golgi organization |
| GO:0008565 |
F |
obsolete protein transporter activity |
| GO:0015031 |
P |
protein transport |
| GO:0016020 |
C |
membrane |
| GO:0017119 |
C |
Golgi transport complex |
| GO:0033227 |
P |
dsRNA transport |
|
| 3063 |
O_ErmoMG14730_complete:A_ErmoMG_comp36876_c0_seq2
393bp |
|
|
| GO:0000002 |
P |
mitochondrial genome maintenance |
| GO:0004518 |
F |
nuclease activity |
| GO:0004527 |
F |
exonuclease activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006264 |
P |
mitochondrial DNA replication |
| GO:0006281 |
P |
DNA repair |
| GO:0006974 |
P |
cellular response to DNA damage stimulus |
| GO:0008297 |
F |
single-stranded DNA exodeoxyribonuclease activity |
| GO:0016787 |
F |
hydrolase activity |
| GO:0043504 |
P |
mitochondrial DNA repair |
| GO:0090305 |
P |
nucleic acid phosphodiester bond hydrolysis |
|
| 3064 |
O_ErmoMG14731_3prime_partial:A_ErmoMG_comp36878_c0_seq1
253bp |
|
|
|
| 3065 |
O_ErmoMG14735_complete:A_ErmoMG_comp36879_c0_seq1
464bp |
|
|
| GO:0004149 |
F |
dihydrolipoyllysine-residue succinyltransferase activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0008152 |
P |
metabolic process |
| GO:0016740 |
F |
transferase activity |
| GO:0016746 |
F |
acyltransferase activity |
| GO:0033512 |
P |
L-lysine catabolic process to acetyl-CoA via saccharopine |
| GO:0045252 |
C |
oxoglutarate dehydrogenase complex |
|
| 3066 |
O_ErmoMG14737_complete:A_ErmoMG_comp36879_c0_seq2
464bp |
|
|
| GO:0004149 |
F |
dihydrolipoyllysine-residue succinyltransferase activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0008152 |
P |
metabolic process |
| GO:0016740 |
F |
transferase activity |
| GO:0016746 |
F |
acyltransferase activity |
| GO:0033512 |
P |
L-lysine catabolic process to acetyl-CoA via saccharopine |
| GO:0045252 |
C |
oxoglutarate dehydrogenase complex |
|
| 3067 |
O_ErmoMG14739_complete:A_ErmoMG_comp36880_c0_seq1
509bp |
|
|
| GO:0000079 |
P |
regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0001933 |
P |
negative regulation of protein phosphorylation |
| GO:0005515 |
F |
protein binding |
| GO:0005575 |
C |
cellular_component |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0005813 |
C |
centrosome |
| GO:0005815 |
C |
microtubule organizing center |
| GO:0005856 |
C |
cytoskeleton |
| GO:0005874 |
C |
microtubule |
| GO:0007095 |
P |
mitotic G2 DNA damage checkpoint signaling |
| GO:0007346 |
P |
regulation of mitotic cell cycle |
| GO:0008283 |
P |
cell population proliferation |
| GO:0010921 |
P |
regulation of phosphatase activity |
| GO:0012505 |
C |
endomembrane system |
| GO:0016020 |
C |
membrane |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030262 |
P |
apoptotic nuclear changes |
| GO:0030332 |
F |
cyclin binding |
| GO:0030968 |
P |
endoplasmic reticulum unfolded protein response |
| GO:0031398 |
P |
positive regulation of protein ubiquitination |
| GO:0032088 |
P |
negative regulation of NF-kappaB transcription factor activity |
| GO:0032403 |
F |
protein-containing complex binding |
| GO:0043234 |
C |
protein-containing complex |
| GO:0043407 |
P |
negative regulation of MAP kinase activity |
| GO:0044387 |
P |
negative regulation of protein kinase activity by regulation of protein phosphorylation |
| GO:0044389 |
F |
ubiquitin-like protein ligase binding |
| GO:0044818 |
P |
mitotic G2/M transition checkpoint |
| GO:0045944 |
P |
positive regulation of transcription by RNA polymerase II |
| GO:0051019 |
F |
mitogen-activated protein kinase binding |
| GO:0051059 |
F |
NF-kappaB binding |
| GO:0071569 |
P |
protein ufmylation |
| GO:0071901 |
P |
negative regulation of protein serine/threonine kinase activity |
| GO:0097371 |
F |
MDM2/MDM4 family protein binding |
| GO:1900182 |
P |
positive regulation of protein localization to nucleus |
| GO:1901798 |
P |
positive regulation of signal transduction by p53 class mediator |
| GO:1903363 |
P |
negative regulation of cellular protein catabolic process |
| GO:2000060 |
P |
positive regulation of ubiquitin-dependent protein catabolic process |
|
| 3068 |
O_ErmoMG1473_complete:A_ErmoMG_comp19777_c0_seq1
350bp |
|
poly(U)-specific_endoribonuclease_homolog_precursor_[Papilio_xuthus] |
| GO:0003723 |
F |
RNA binding |
| GO:0004518 |
F |
nuclease activity |
| GO:0004519 |
F |
endonuclease activity |
| GO:0004521 |
F |
endoribonuclease activity |
| GO:0005575 |
C |
cellular_component |
| GO:0005576 |
C |
extracellular region |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016788 |
F |
hydrolase activity, acting on ester bonds |
| GO:0046872 |
F |
metal ion binding |
| GO:0090502 |
P |
RNA phosphodiester bond hydrolysis, endonucleolytic |
|
| 3069 |
O_ErmoMG14740_5prime_partial:A_ErmoMG_comp36881_c0_seq1
333bp |
|
|
| GO:0003674 |
F |
molecular_function |
| GO:0005737 |
C |
cytoplasm |
| GO:0005813 |
C |
centrosome |
| GO:0005815 |
C |
microtubule organizing center |
| GO:0005856 |
C |
cytoskeleton |
| GO:0008150 |
P |
biological_process |
| GO:0016567 |
P |
protein ubiquitination |
| GO:0080008 |
C |
Cul4-RING E3 ubiquitin ligase complex |
|
| 3070 |
O_ErmoMG14743_3prime_partial:A_ErmoMG_comp36881_c0_seq2
121bp |
|
|
|
| 3071 |
O_ErmoMG14744_complete:A_ErmoMG_comp36882_c1_seq1
305bp |
|
|
| GO:0000050 |
P |
urea cycle |
| GO:0000064 |
F |
L-ornithine transmembrane transporter activity |
| GO:0000066 |
P |
mitochondrial L-ornithine transmembrane transport |
| GO:0003735 |
F |
structural constituent of ribosome |
| GO:0005739 |
C |
mitochondrion |
| GO:0005743 |
C |
mitochondrial inner membrane |
| GO:0006412 |
P |
translation |
| GO:0006520 |
P |
cellular amino acid metabolic process |
| GO:0006810 |
P |
transport |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:1903352 |
P |
L-ornithine transmembrane transport |
|
| 3072 |
O_ErmoMG14749_complete:A_ErmoMG_comp36884_c0_seq1
641bp |
|
|
| GO:0005576 |
C |
extracellular region |
| GO:0008152 |
P |
metabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0052689 |
F |
carboxylic ester hydrolase activity |
|
| 3073 |
O_ErmoMG14750_3prime_partial:A_ErmoMG_comp36885_c0_seq1
221bp |
|
|
| GO:0004062 |
F |
aryl sulfotransferase activity |
| GO:0005575 |
C |
cellular_component |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0008146 |
F |
sulfotransferase activity |
| GO:0016740 |
F |
transferase activity |
| GO:0050427 |
P |
3'-phosphoadenosine 5'-phosphosulfate metabolic process |
| GO:0051923 |
P |
sulfation |
|
| 3074 |
O_ErmoMG14751_5prime_partial:A_ErmoMG_comp36885_c0_seq2
105bp |
|
|
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0008146 |
F |
sulfotransferase activity |
| GO:0008202 |
P |
steroid metabolic process |
| GO:0016740 |
F |
transferase activity |
|
| 3075 |
O_ErmoMG14752_internal:A_ErmoMG_comp36885_c0_seq4
253bp |
|
|
| GO:0004062 |
F |
aryl sulfotransferase activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006584 |
P |
catecholamine metabolic process |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0008146 |
F |
sulfotransferase activity |
| GO:0008202 |
P |
steroid metabolic process |
| GO:0016740 |
F |
transferase activity |
|
| 3076 |
O_ErmoMG14753_complete:A_ErmoMG_comp36886_c0_seq1
704bp |
|
|
| GO:0000166 |
F |
nucleotide binding |
| GO:0001676 |
P |
long-chain fatty acid metabolic process |
| GO:0003824 |
F |
catalytic activity |
| GO:0004467 |
F |
long-chain fatty acid-CoA ligase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0016874 |
F |
ligase activity |
|
| 3077 |
O_ErmoMG14754_complete:A_ErmoMG_comp36887_c0_seq1
560bp |
|
|
|
| 3078 |
O_ErmoMG14756_complete:A_ErmoMG_comp36887_c0_seq2
529bp |
|
|
|
| 3079 |
O_ErmoMG14758_complete:A_ErmoMG_comp36888_c0_seq1
360bp |
|
|
| GO:0005515 |
F |
protein binding |
| GO:0005783 |
C |
endoplasmic reticulum |
| GO:0005794 |
C |
Golgi apparatus |
| GO:0005886 |
C |
plasma membrane |
| GO:0006810 |
P |
transport |
| GO:0006855 |
P |
xenobiotic transmembrane transport |
| GO:0006869 |
P |
lipid transport |
| GO:0010976 |
P |
positive regulation of neuron projection development |
| GO:0015914 |
P |
phospholipid transport |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016324 |
C |
apical plasma membrane |
| GO:0030658 |
C |
transport vesicle membrane |
| GO:0031410 |
C |
cytoplasmic vesicle |
| GO:0036010 |
P |
protein localization to endosome |
| GO:0045332 |
P |
phospholipid translocation |
| GO:0070863 |
P |
positive regulation of protein exit from endoplasmic reticulum |
|
| 3080 |
O_ErmoMG1475_complete:A_ErmoMG_comp19787_c0_seq1
158bp |
|
PREDICTED:_prefoldin_subunit_5_[Bombyx_mori] |
| GO:0005634 |
C |
nucleus |
| GO:0006457 |
P |
protein folding |
| GO:0016272 |
C |
prefoldin complex |
| GO:0045892 |
P |
negative regulation of transcription, DNA-templated |
| GO:0051082 |
F |
unfolded protein binding |
| GO:0060041 |
P |
retina development in camera-type eye |
| GO:0090090 |
P |
negative regulation of canonical Wnt signaling pathway |
|
| 3081 |
O_ErmoMG14760_complete:A_ErmoMG_comp36890_c0_seq1
753bp |
|
|
| GO:0005520 |
F |
insulin-like growth factor binding |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0005654 |
C |
nucleoplasm |
| GO:0007155 |
P |
cell adhesion |
| GO:0042567 |
C |
insulin-like growth factor ternary complex |
| GO:0070062 |
C |
extracellular exosome |
|
| 3082 |
O_ErmoMG14761_complete:A_ErmoMG_comp36891_c0_seq1
255bp |
|
|
| GO:0000062 |
F |
fatty-acyl-CoA binding |
| GO:0005737 |
C |
cytoplasm |
| GO:0008289 |
F |
lipid binding |
|
| 3083 |
O_ErmoMG14762_5prime_partial:A_ErmoMG_comp36891_c0_seq1
242bp |
|
|
| GO:0005737 |
C |
cytoplasm |
| GO:0008168 |
F |
methyltransferase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016740 |
F |
transferase activity |
| GO:0032259 |
P |
methylation |
|
| 3084 |
O_ErmoMG14763_internal:A_ErmoMG_comp36892_c0_seq1
614bp |
|
|
| GO:0004222 |
F |
metalloendopeptidase activity |
| GO:0004867 |
F |
serine-type endopeptidase inhibitor activity |
| GO:0005201 |
F |
extracellular matrix structural constituent |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005604 |
C |
basement membrane |
| GO:0006508 |
P |
proteolysis |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008233 |
F |
peptidase activity |
| GO:0008237 |
F |
metallopeptidase activity |
| GO:0008270 |
F |
zinc ion binding |
| GO:0010466 |
P |
negative regulation of peptidase activity |
| GO:0010951 |
P |
negative regulation of endopeptidase activity |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030414 |
F |
peptidase inhibitor activity |
| GO:0031012 |
C |
extracellular matrix |
|
| 3085 |
O_ErmoMG14768_internal:A_ErmoMG_comp36892_c0_seq2
591bp |
|
|
| GO:0004222 |
F |
metalloendopeptidase activity |
| GO:0004867 |
F |
serine-type endopeptidase inhibitor activity |
| GO:0005201 |
F |
extracellular matrix structural constituent |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005604 |
C |
basement membrane |
| GO:0006508 |
P |
proteolysis |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008233 |
F |
peptidase activity |
| GO:0008237 |
F |
metallopeptidase activity |
| GO:0008270 |
F |
zinc ion binding |
| GO:0010466 |
P |
negative regulation of peptidase activity |
| GO:0010951 |
P |
negative regulation of endopeptidase activity |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030414 |
F |
peptidase inhibitor activity |
| GO:0031012 |
C |
extracellular matrix |
|
| 3086 |
O_ErmoMG1476_internal:A_ErmoMG_comp19792_c0_seq1
142bp |
|
PREDICTED:_LOW_QUALITY_PROTEIN:_protein_split_ends_[Bombyx_mori] |
|
| 3087 |
O_ErmoMG14773_internal:A_ErmoMG_comp36892_c1_seq1
460bp |
|
|
| GO:0004222 |
F |
metalloendopeptidase activity |
| GO:0004867 |
F |
serine-type endopeptidase inhibitor activity |
| GO:0005201 |
F |
extracellular matrix structural constituent |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005604 |
C |
basement membrane |
| GO:0006508 |
P |
proteolysis |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008233 |
F |
peptidase activity |
| GO:0008237 |
F |
metallopeptidase activity |
| GO:0008270 |
F |
zinc ion binding |
| GO:0010466 |
P |
negative regulation of peptidase activity |
| GO:0010951 |
P |
negative regulation of endopeptidase activity |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030414 |
F |
peptidase inhibitor activity |
| GO:0031012 |
C |
extracellular matrix |
|
| 3088 |
O_ErmoMG14776_5prime_partial:A_ErmoMG_comp36892_c1_seq2
373bp |
|
|
| GO:0004222 |
F |
metalloendopeptidase activity |
| GO:0004867 |
F |
serine-type endopeptidase inhibitor activity |
| GO:0005201 |
F |
extracellular matrix structural constituent |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005604 |
C |
basement membrane |
| GO:0006508 |
P |
proteolysis |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008233 |
F |
peptidase activity |
| GO:0008237 |
F |
metallopeptidase activity |
| GO:0008270 |
F |
zinc ion binding |
| GO:0010466 |
P |
negative regulation of peptidase activity |
| GO:0010951 |
P |
negative regulation of endopeptidase activity |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030414 |
F |
peptidase inhibitor activity |
| GO:0031012 |
C |
extracellular matrix |
|
| 3089 |
O_ErmoMG14779_5prime_partial:A_ErmoMG_comp36892_c1_seq3
388bp |
|
|
| GO:0004222 |
F |
metalloendopeptidase activity |
| GO:0004867 |
F |
serine-type endopeptidase inhibitor activity |
| GO:0005201 |
F |
extracellular matrix structural constituent |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005604 |
C |
basement membrane |
| GO:0006508 |
P |
proteolysis |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008233 |
F |
peptidase activity |
| GO:0008237 |
F |
metallopeptidase activity |
| GO:0008270 |
F |
zinc ion binding |
| GO:0010466 |
P |
negative regulation of peptidase activity |
| GO:0010951 |
P |
negative regulation of endopeptidase activity |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030414 |
F |
peptidase inhibitor activity |
| GO:0031012 |
C |
extracellular matrix |
|
| 3090 |
O_ErmoMG14782_internal:A_ErmoMG_comp36892_c1_seq4
325bp |
|
|
| GO:0004222 |
F |
metalloendopeptidase activity |
| GO:0004867 |
F |
serine-type endopeptidase inhibitor activity |
| GO:0005201 |
F |
extracellular matrix structural constituent |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005604 |
C |
basement membrane |
| GO:0006508 |
P |
proteolysis |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008233 |
F |
peptidase activity |
| GO:0008237 |
F |
metallopeptidase activity |
| GO:0008270 |
F |
zinc ion binding |
| GO:0010466 |
P |
negative regulation of peptidase activity |
| GO:0010951 |
P |
negative regulation of endopeptidase activity |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030414 |
F |
peptidase inhibitor activity |
| GO:0031012 |
C |
extracellular matrix |
|
